OCUL
OCUL
US67576A1007
Ocular Therapeutix, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 51.951.000 63.723.000
18.5%
Cost of Revenue 6.574.000 5.626.000
16.9%
Gross Profit 45.377.000 58.097.000
21.9%
315.394.000 229.878.000
37.2%
Operating Income -270.017.000 -171.781.000
57.2%
Pretax Income -265.939.000 -193.506.000
37.4%
Net Income Common Stockholders -265.939.000 -193.506.000
37.4%
-- --
--
-- --
--
ende